540686 Stock Overview
Manufactures and markets active pharmaceutical ingredients (API) to pharmaceutical companies in India, Asia, Africa, the Americas, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Smruthi Organics Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹165.70 |
| 52 Week High | ₹218.80 |
| 52 Week Low | ₹118.90 |
| Beta | 0.80 |
| 11 Month Change | 3.40% |
| 3 Month Change | 8.02% |
| 1 Year Change | 35.93% |
| 33 Year Change | -56.14% |
| 5 Year Change | 247.62% |
| Change since IPO | 185.53% |
Recent News & Updates
Recent updates
Shareholder Returns
| 540686 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 3.5% | 2.2% | -1.0% |
| 1Y | 35.9% | 46.7% | 43.6% |
Return vs Industry: 540686 underperformed the Indian Pharmaceuticals industry which returned 46.7% over the past year.
Return vs Market: 540686 underperformed the Indian Market which returned 43.6% over the past year.
Price Volatility
| 540686 volatility | |
|---|---|
| 540686 Average Weekly Movement | 5.1% |
| Pharmaceuticals Industry Average Movement | 5.7% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in IN Market | 9.7% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 540686 has not had significant price volatility in the past 3 months.
Volatility Over Time: 540686's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 308 | Purushotham Eaga | www.smruthiorganics.com |
Smruthi Organics Limited manufactures and markets active pharmaceutical ingredients (API) to pharmaceutical companies in India, Asia, Africa, the Americas, and internationally. It API products include amlodipine besilate, losartan potassium, telmisartan, s - amlodipine besilate, s - amlodipine malelate, and valsartan for cardiovascular; metformin HCL, vildagliptin, teneligliptin, and dapagliflozin for anti-diabetic; ciprofloxacin HCL, diloxanide furoate, norfloxacin, and pefloxacin mesylate for anti-infective applications; and ticagrelor for anti-platelets. The company also offers drug intermediates, such as amlodipine base, s-amlodipine base, and phthaloyl amlodipine, as well as bulk drugs.
Smruthi Organics Limited Fundamentals Summary
| 540686 fundamental statistics | |
|---|---|
| Market cap | ₹1.90b |
| Earnings (TTM) | ₹35.90m |
| Revenue (TTM) | ₹1.28b |
52.8x
P/E Ratio1.5x
P/S RatioIs 540686 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 540686 income statement (TTM) | |
|---|---|
| Revenue | ₹1.28b |
| Cost of Revenue | ₹723.54m |
| Gross Profit | ₹552.89m |
| Other Expenses | ₹516.99m |
| Earnings | ₹35.90m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Jul 27, 2024
| Earnings per share (EPS) | 3.14 |
| Gross Margin | 43.32% |
| Net Profit Margin | 2.81% |
| Debt/Equity Ratio | 16.8% |
How did 540686 perform over the long term?
See historical performance and comparison